Works matching IS 13524585 AND DT 2021 AND VI 27 AND IP 3

Results: 21

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 430, doi. 10.1177/1352458520974366

By:

Iaffaldano, Pietro;
Lucisano, Giuseppe;
Patti, Francesco;
Brescia Morra, Vincenzo;
De Luca, Giovanna;
Lugaresi, Alessandra;
Zaffaroni, Mauro;
Inglese, Matilde;
Salemi, Giuseppe;
Cocco, Eleonora;
Conte, Antonella;
Ferraro, Diana;
Galgani, Simonetta;
Bergamaschi, Roberto;
Pozzilli, Carlo;
Salvetti, Marco;
Lus, Giacomo;
Rovaris, Marco;
Maniscalco, Giorgia Teresa;
Logullo, Francesco Ottavio

Publication type:

Article

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 465, doi. 10.1177/1352458520921087

By:

Lizak, Nathaniel;
Hodgkinson, Suzanne;
Butler, Ernest;
Lechner-Scott, Jeannette;
Slee, Mark;
McCombe, Pamela Ann;
Shaw, Cameron;
Skibina, Olga;
Vucic, Steve;
Shuey, Neil;
Barnett, Michael H;
Parratt, John;
Butzkueven, Helmut;
Jack, Dominic;
Fabris, Jessica;
Kalincik, Tomas

Publication type:

Article

Patient-reported financial toxicity in multiple sclerosis: Predictors and association with care non-adherence.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 453, doi. 10.1177/1352458520913977

By:

Sadigh, Gelareh;
Lava, Neil;
Switchenko, Jeffrey;
Duszak Jr, Richard;
Krupinski, Elizabeth A;
Meltzer, Carolyn;
Hughes, Danny;
Carlos, Ruth C

Publication type:

Article

When does a heap become a heap?

Published in:

2021

By:

Lorscheider, Johannes

Publication type:

Editorial

7 Tesla MRI will soon be helpful to guide clinical practice in multiple sclerosis centers – Commentary.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 364, doi. 10.1177/1352458520981738

By:

Sati, Pascal;
Reich, Daniel S

Publication type:

Article

7 Tesla MRI will soon be helpful to guide clinical practice in multiple sclerosis centres – Yes.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 360, doi. 10.1177/1352458520972270

By:

Louapre, Céline;
Beigneux, Ysoline

Publication type:

Article

7 Tesla MRI will soon be helpful to guide clinical practice in multiple sclerosis centres – No.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 362, doi. 10.1177/1352458520969662

By:

Gonzalez-Escamilla, Gabriel;
Groppa, Sergiu

Publication type:

Article

Powered exoskeletons for walking in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 487, doi. 10.1177/1352458520958351

By:

Feys, Peter;
Swinnen, Eva

Publication type:

Article

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 347, doi. 10.1177/1352458520952310

By:

Riva, Agostino;
Barcella, Valeria;
Benatti, Simone V;
Capobianco, Marco;
Capra, Ruggero;
Cinque, Paola;
Comi, Giancarlo;
Fasolo, Maria Michela;
Franzetti, Fabio;
Galli, Massimo;
Gerevini, Simonetta;
Meroni, Luca;
Origoni, Massimo;
Prosperini, Luca;
Puoti, Massimo;
Scarpazza, Cristina;
Tortorella, Carla;
Zaffaroni, Mauro;
Moiola, Lucia

Publication type:

Article

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 331, doi. 10.1177/1352458520952311

By:

Moiola, Lucia;
Barcella, Valeria;
Benatti, Simone;
Capobianco, Marco;
Capra, Ruggero;
Cinque, Paola;
Comi, Giancarlo;
Fasolo, Maria Michela;
Franzetti, Fabio;
Galli, Massimo;
Gerevini, Simonetta;
Meroni, Luca;
Origoni, Massimo;
Prosperini, Luca;
Puoti, Massimo;
Scarpazza, Cristina;
Tortorella, Carla;
Zaffaroni, Mauro;
Riva, Agostino

Publication type:

Article

Enhancing quality of life in progressive multiple sclerosis with powered robotic exoskeleton.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 483, doi. 10.1177/1352458520943080

By:

Wee, Seng Kwee;
Ho, Chiu Yi;
Tan, Si Lei;
Ong, Cheng Hong

Publication type:

Article

The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 479, doi. 10.1177/1352458520930620

By:

Ghezzi, Angelo;
Amato, Maria Pia;
Edan, Gilles;
Hartung, Hans-Peter;
Havrdová, Eva Kubala;
Kappos, Ludwig;
Montalban, Xavier;
Pozzilli, Carlo;
Sorensen, Per Soelber;
Trojano, Maria;
Vermersch, Patrich;
Comi, Giancarlo

Publication type:

Article

Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 475, doi. 10.1177/1352458520929628

By:

Pauliat, Emmanuelle;
Onken, Marlies;
Weber-Schoendorfer, Corinna;
Rousson, Valentin;
Addor, Marie-Claude;
Baud, David;
Théaudin, Marie;
Diav-Citrin, Orna;
Cottin, Judith;
Agusti, Antonia;
Rollason, Victoria;
Kaplan, Yusuf C;
Kennedy, Debra;
Kadioglu, Mine;
Rothuizen, Laura E;
Livio, Françoise;
Buclin, Thierry;
Panchaud, Alice;
Winterfeld, Ursula

Publication type:

Article

Household paired design reduces variance and increases power in multi-city gut microbiome study in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 366, doi. 10.1177/1352458520924594

By:

Zhou, Xiaoyuan;
Singh, Sneha;
Baumann, Ryan;
Barba, Patrick;
Landefeld, James;
Casaccia, Patrizia;
Sand, Ilana Katz;
Xia, Zongqi;
Weiner, Howard;
Chitnis, Tanuja;
Chandran, Siddharthan;
Connick, Peter;
Otaegui, David;
Castillo-Triviño, Tamara;
Caillier, Stacy J.;
Santaniello, Adam;
Ackermann, Gail;
Humphrey, Greg;
Negrotto, Laura;
Farez, Mauricio

Publication type:

Article

Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 380, doi. 10.1177/1352458520918978

By:

Kiljan, Svenja;
Preziosa, Paolo;
Jonkman, Laura E;
van de Berg, Wilma DJ;
Twisk, Jos;
Pouwels, Petra JW;
Schenk, Geert J;
Rocca, Maria A;
Filippi, Massimo;
Geurts, Jeroen JG;
Steenwijk, Martijn D

Publication type:

Article

Do subcortical gray matter volumes and aerobic capacity account for cognitive-motor coupling in multiple sclerosis?

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 401, doi. 10.1177/1352458520914822

By:

Motl, Robert W;
Sandroff, Brian M;
Benedict, Ralph HB;
Hubbard, Elizabeth A;
Pilutti, Lara A;
Sutton, Bradley P

Publication type:

Article

Recurrence of clinical events at the same anatomical location in patients with MOG antibody-associated disease.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 449, doi. 10.1177/1352458520913970

By:

Hyun, Jae-Won;
Kwon, Young Nam;
Lee, Hye Lim;
Jeong, Woo Kyo;
Lee, Hye Jung;
Kim, Byoung Joon;
Kim, Seung Woo;
Shin, Ha Young;
Shin, Hyun-June;
Oh, Sun-Young;
Lee, Min Young;
Kim, Su-Hyun;
Huh, So-Young;
Kim, Woojun;
Park, Min Su;
Kim, Sun-Young;
Kim, Sung-Min;
Kim, Ho Jin

Publication type:

Article

Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 439, doi. 10.1177/1352458520918489

By:

von Wyl, Viktor;
Benkert, Pascal;
Moser, André;
Lorscheider, Johannes;
Décard, Bernhard;
Hänni, Peter;
Lienert, Carmen;
Kuhle, Jens;
Derfuss, Tobias;
Kappos, Ludwig;
Yaldizli, Özgür

Publication type:

Article

A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 420, doi. 10.1177/1352458520918375

By:

Fox, Edward;
Lovett-Racke, Amy E;
Gormley, Matthew;
Liu, Yue;
Petracca, Maria;
Cocozza, Sirio;
Shubin, Richard;
Wray, Sibyl;
Weiss, Michael S;
Bosco, Jenna A;
Power, Sean A;
Mok, Koby;
Inglese, Matilde

Publication type:

Article

Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri ® Observational Program (TOP).

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 410, doi. 10.1177/1352458520917925

By:

Butzkueven, Helmut;
Trojano, Maria;
Kappos, Ludwig;
Spelman, Tim;
Wiendl, Heinz;
Rosales, Karen;
Su, Ray;
Licata, Stephanie;
Ho, Pei-Ran;
Campbell, Nolan

Publication type:

Article

Predictive value of optical coherence tomography, multifocal visual evoked potentials, and full-field visual evoked potentials of the fellow, non-symptomatic eye for subsequent multiple sclerosis development in patients with acute optic neuritis.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 391, doi. 10.1177/1352458520917924

By:

Pihl-Jensen, Gorm;
Wanscher, Benedikte;
Frederiksen, Jette Lautrup

Publication type:

Article